Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.
DAY 3SOLACIStructural heart disease

SOLACI CACI 2017 | When is the optimal timing for PCI: before or during TAVI

solaci
solaci
638
0
Dr. Conrad Simpfendorfer
Dr. Conrad Simpfendorfer

Read articles on the main presentations of the third day of SOLACI-CACI 2017 Congress.

See the presentation by Dr. Conrad Simpfendorfer, entitled “When is the optimal timing for PCI: before or during TAVI”.

4Simpfendorer-Conradintro

4Simpfendorfer-Conrad

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

Previous article
SOLACI CACI 2017 | Can the new platforms change the practice?
Next article
SOLACI CACI 2017 | Is the PCI risk higher in patients with severe Aortic Stenosis? How can we reduce the risk?
solaci
solaci

More articles by this author

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

Dr. Juan Manuel Pérez - 0
The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

Dr. Andrés Rodríguez - 0
This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

Dr. Andrés Rodríguez - 0
The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | Is localized anticoagulation the next step for coronary stents?

Dr. Juan Manuel Pérez - 0
The DESyne BDS Plus stent was developed as a thin-strut, bioabsorbable polymer drug-eluting stent that combines sirolimus release with two anticoagulant agents (rivaroxaban and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Structural heart disease

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which...
Dr. Juan Manuel Pérez -
SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

Dr. Juan Manuel Pérez - 0
The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

Dr. Andrés Rodríguez - 0
This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

Dr. Andrés Rodríguez - 0
The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...